Stemline Therapeutics, Inc. - Product Pipeline Review

Global Markets Direct’s, ‘Stemline Therapeutics, Inc. - Product Pipeline Review - 2016’, provides an overview of the Stemline Therapeutics, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Stemline Therapeutics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Stemline Therapeutics, Inc.

The report provides overview of Stemline Therapeutics, Inc. including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Stemline Therapeutics, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Stemline Therapeutics, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Stemline Therapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Stemline Therapeutics, Inc.

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Stemline Therapeutics, Inc.’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Stemline Therapeutics, Inc. Snapshot 6

Stemline Therapeutics, Inc. Overview 6 ...

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Stemline Therapeutics, Inc. Snapshot 6

Stemline Therapeutics, Inc. Overview 6

Key Information 6

Key Facts 6

Stemline Therapeutics, Inc. - Research and Development Overview 7

Key Therapeutic Areas 7

Stemline Therapeutics, Inc. - Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products - Monotherapy 11

Stemline Therapeutics, Inc. - Pipeline Products Glance 12

Stemline Therapeutics, Inc. - Clinical Stage Pipeline Products 12

Phase II Products/Combination Treatment Modalities 12

Phase I Products/Combination Treatment Modalities 13

Stemline Therapeutics, Inc. - Early Stage Pipeline Products 14

Preclinical Products/Combination Treatment Modalities 14

Stemline Therapeutics, Inc. - Drug Profiles 15

SL-401 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

SL-701 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

SL-801 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

Monoclonal Antibodies to Inhibit IL-3RA for Autoimmune Disorders 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Monoclonal Antibody to Antagonize Frizzled Receptor for Oncology 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

Monoclonal Antibody to Antagonize Patched for Oncology 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

Monoclonal Antibody to Antagonize Tie-1 Receptor for Oncology 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

Monoclonal Antibody to Inhibit CD133 for Oncology 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

Monoclonal Antibody to Inhibit Glypican-3 for Oncology 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

Monoclonal Antibody to Inhibit Smoothened for Oncology 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

SL-101 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

SL-201 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

SL-202 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

SL-301 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

SL-302 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

SL-501 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

SL-601 35

Product Description 35

Mechanism of Action 35

R&D Progress 35

Stemline Therapeutics, Inc. - Pipeline Analysis 36

Stemline Therapeutics, Inc. - Pipeline Products by Target 36

Stemline Therapeutics, Inc. - Pipeline Products by Route of Administration 37

Stemline Therapeutics, Inc. - Pipeline Products by Molecule Type 38

Stemline Therapeutics, Inc. - Pipeline Products by Mechanism of Action 39

Stemline Therapeutics, Inc. - Recent Pipeline Updates 40

Stemline Therapeutics, Inc. - Dormant Projects 46

Stemline Therapeutics, Inc. - Locations And Subsidiaries 47

Head Office 47

Appendix 48

Methodology 48

Coverage 48

Secondary Research 48

Primary Research 48

Expert Panel Validation 48

Contact Us 48

Disclaimer 49

List of Tables

List of Tables

Stemline Therapeutics, Inc., Key Information 6

Stemline Therapeutics, Inc., Key Facts 6

Stemline Therapeutics, Inc. - Pipeline by Indication, 2016 8

Stemline ...

List of Tables

Stemline Therapeutics, Inc., Key Information 6

Stemline Therapeutics, Inc., Key Facts 6

Stemline Therapeutics, Inc. - Pipeline by Indication, 2016 8

Stemline Therapeutics, Inc. - Pipeline by Stage of Development, 2016 10

Stemline Therapeutics, Inc. - Monotherapy Products in Pipeline, 2016 11

Stemline Therapeutics, Inc. - Phase II, 2016 12

Stemline Therapeutics, Inc. - Phase I, 2016 13

Stemline Therapeutics, Inc. - Preclinical, 2016 14

Stemline Therapeutics, Inc. - Pipeline by Target, 2016 36

Stemline Therapeutics, Inc. - Pipeline by Route of Administration, 2016 37

Stemline Therapeutics, Inc. - Pipeline by Molecule Type, 2016 38

Stemline Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2016 39

Stemline Therapeutics, Inc. - Recent Pipeline Updates, 2016 40

Stemline Therapeutics, Inc. - Dormant Developmental Projects,2016 46

List of Figures

List of Figures

Stemline Therapeutics, Inc. - Pipeline by Top 10 Indication, 2016 8

Stemline Therapeutics, Inc. - Pipeline by Stage of Development, 2016 10 ...

List of Figures

Stemline Therapeutics, Inc. - Pipeline by Top 10 Indication, 2016 8

Stemline Therapeutics, Inc. - Pipeline by Stage of Development, 2016 10

Stemline Therapeutics, Inc. - Monotherapy Products in Pipeline, 2016 11

Stemline Therapeutics, Inc. - Pipeline by Top 10 Target, 2016 36

Stemline Therapeutics, Inc. - Pipeline by Route of Administration, 2016 37

Stemline Therapeutics, Inc. - Pipeline by Molecule Type, 2016 38

Stemline Therapeutics, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016 39

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports